Expanded Access Programs (EAPs), sometimes known as Managed Access Programmes (MAPs), allow pharmaceutical sponsors to offer patients their pre-approval investigational
For years, the prospect of ‘virtual’ and decentralised research was discussed with hope as a potential disruptor to enable greater
Cisiv partnered with a specialist CRO and a Medical Device Company (IVD Sponsor) to conduct an end-to-end process for clinical
Get in touch today to speak to one of our expert team and find out how we can help you with your study.
© Copyright Cisiv 2024 | Registered Company Number: 3110147
© Copyright Cisiv
To find out more about the Cisiv technology and how we can help you with your study.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |